China (Mainland)
Premiumsupplier 
- Product Details
Keywords
- 1-Methylimidazole
- N-methylimidazole
- N-methyl glyoxaline
Quick Details
- ProName: 1-Methylimidazole
- CasNo: 616-47-7
- Molecular Formula: C4H6N2
- Appearance: Light yellow or transparent liquid
- Application: pharmaceutical intermediate.
- DeliveryTime: 7-15 working days
- PackAge: NW 1kg/foil bag; 20-25kg/drum or carto...
- Port: Shanghai/ Guangzhou/any other ports in...
- ProductionCapacity: 20 Metric Ton/Month
- Purity: ≥ 99.0%
- Storage: Stored in a dark, cool, ventilated and...
- Transportation: by air/sea/express,according to demand...
- LimitNum: 1 Kilogram
Superiority
Specification
|
items |
standard |
Result |
|
Appearance |
Light yellow or transparent liquid
|
Colorless and transparent liquid |
|
Purity |
≥99.00%(GC) |
99.67%(GC) |
|
Water |
≤0.50%(KF) |
0.10%(KF) |
|
Chromaticity |
≤70APHA(25℃) |
20APHA(25℃) |
|
Density |
1.030-1.040g/ml(20℃） |
1.036g/ml（20℃) |
|
Conclusion |
Qualified |
Details
Wuhan BJM Pharm Inc. was found in 2013, located in Hubei Province, where has long history, rich culture, convenient traffic, beautiful environment and preferential policy.
We have two factories in Dezhou , Shandong and Xianning, Hubei. The factory covers an area of 48,000 square meters with the building area of 26,000 square meters. We are specialized in the manufacture of pharmaceutical intermediates and cosmetic additives with good inspection equipments and innovative R & D capability.
In 2006, We established Lingxian Microworld Chemical New Material Co,.Ltd.
In 2008, We passed ISO quality system certificate
In 2013, We established Wuhan Benjamin Pharmaceutical Chemical Co.,Ltd , and obtain self-operation Import & Export right, mainly responsible for domestic and foreign business. At the same time, we set up R&D lab in Wuhan,Hubei province, can undertake various custom synthesis of intermediates and APIs.
In 2016, obtain a registered trademark “ BJM ”.
In 2017, we applied for the invention patent of TRIS, and in 2018, we applied for the invention patent of ERDOSTAN intermediate（DL-HOMO）. At present, we have6 patents passed the preliminary examination, and 4 patents are under examination and approval.
In 2019, we purchased a R&D and office building with a total area of 2500 square meters, as our headquarters in Wuhan.
In 2020, we registered BJM Pharm Yunmeng Co., Ltd, and the new production base settled in Geputan chemical park with a total area of 50000 square meters.
We are specialized in the R&D ,production and sales of Erdosteine ,Pirfenidone, Telmisartan, Letrozole , Sitagliptin phosphate, Dapagliflozin , Tris , IPTG and related intermediates.
We stick to the principle as: people-oriented, customer first, Hope to establish a win-win business relationship with all friends.